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Ukraine
Objective:
 
 The assessment of relationships between particularities of dys-
lipidemia (DL) and arterial hypertension (H).
 
Methods:
 
 184 patients (pts) (85 males and 99 females, average age
52.5±3.5 years) with different cardiovascular pathology (excluding acute cor-
onary syndrome) were enrolled in the study. DL without H was the criterion
of inclusion to the study. The evaluation of total cholesterol (TC), low density
lipoproteins (LDL) cholesterol, very low density lipoproteins (VLDL) choles-
terol, high density lipoproteins (HDL) cholesterol and triglycerides (TG) was
done as obligatory test. The investigations were performed every 6 months
during 3 years.
 
Results:
 
 The pts were divided into 3 groups (grs) according to time of H
development. 48 pts (26.1%) with history of H during 1st year of follow-up
were included in 1 gr. 43 pts (23.4%) with history of H during 2nd year of
follow-up were included in 2 gr. 55 pts (29.9%) with history of H during 3rd
year of follow-up were included in 3 gr. 38 pts (20.7%) without H during 3rd
year of follow-up were included in 4 gr. The TG elevation was detected in
69% of pts in 1 gr (1.98±0.08 mmol/l), 60% of pts in 2 gr (1.90±0.1 mmol/l)
and 54% of pts in 3 gr (1.87±0.09 mmol/l).
The combined elevation of TG and LDL-cholesterol was detected in 63%
of pts in 1 gr (1.96±0.10 mmol/l and 4.54±0.08 mmol/l), in 55% of pts in 2 gr
(1.90±0.07 mmol/l and 4.22±0.12 mmol/l), in 63% of pts in 1 gr (1.86±0.09
mmol/l and 4.08±0.08 mmol/l). Pts from 4 gr had isolated elevation of TC (18
pts (47.4%) – 6.84±0.09 mmol/l), combined elevation of TC and VLDL-cho-
lesterol (11 pts (28.9%), 6.72±0.07 mmol/l and 0.65±0.07 mmol/l, accord-
ingly), combined elevation of LDL-cholesterol and VLDL-cholesterol (9 pts
(23.7%), 4.12±0.06 mmol/l and 0.52±0.07 mmol/l, accordingly)
 
Conclusions: 
 
The elevated level of TG is the most significant factor for
origin of H. Further progression of H is related to TG and LDL-cholesterol
levels. 
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Introduction: While there are much data on the risk factors involved in the
onset of atherothrombotic stroke (AS) or acute coronary syndrome (ACS), few
studies have compared the prevalence of metabolic syndrome (MS) and insulin
resistance (IR) in the occurrence of these events.
Methods: In a pilot study, prospective, comparative, single centre, 137
patients who presented an AS (N= 68) or ACS (N= 69) were consecutively
included. The cardiovascular risk factors (CRF) were collected, the prevalence
of MS was determined using « the National Cholesterol Education Program
Adult Treatment Panel III (NCEP-ATPIII) and the International Diabetes Fed-
eration (IDF) definitions. IR was determined using the homeostasis model
assessment of insulin resistance (HOMA-IR) in patients without insulin treat-
ment.
Results: There were no significant differences between groups for history
of hypertension or diabetes, cardiovascular heredity, body mass index, nor
lipid parameters. Sex ratio was similar in both groups but AS patients were
older (58.2±8.4 vs. 54.0±8.8 respectively, p=0.006. Active smoking was more
prevalent in the ACS group (30 vs. 18%, p=0.04). Plasma glucose and insulin
levels were higher in the ACS group (5.59±1.86 vs. 5.0±1.0 mmol/l, p=0.04;
9. ±1.04 vs. 6.7±3.6 µUI/ml, p=0.04, respectively). There was no difference in
the prevalence of MS between ACS and AS groups, using NCEP-ATPIII defi-
nition (11 vs. 12 %, p=NS) or IDF definitions (26 vs. 23%, p=NS). There was
a significantly higher IR in the ACS group (HOMA-IR 2.17+1.90 vs.
1.50+0.81, p=0.03). 
Conclusion: In our study, distribution of cardiovascular risk factors is dif-
ferent according to the athero-thrombotic disease. The metabolic disturbances
in particular IR seems to be predominant in the onset of ACS.
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Background: The traditional method of calculation of the ankle-brachial
index (ABI) and the usual 0.90 threshold have been recently challenged by
alternate methods and values proposed as more sensitive to predict cardiovas-
cular mortality. However the overall discriminative value of the ABI using dif-
ferent modes of calculation has not been systematically performed.
Methods: We assessed the ABI to predict the 5-years mortality of 705
patients who underwent coronary bypass surgery. We  compared the ROC
curves of 6 modes of ABI calculation, combining 3 different numerators (the
highest (high), the mean (mean) and the lowest (low) pressure of posterior
tibial and anterior tibial arteries) with 2 denominators (the highest (high) or the
mean (mean) systolic pressure of both arms).
Results: During follow-up, 97 (13.8%) patients died. The area under the
curves (AUC) of the 6 methods to predict 5-years mortality were similar
(Table). Only the AUC of method “High/High” was significantly (p<0.05)
higher than method “High/Mean” and “Low/Mean”. The most accurate
threshold to predict mortality differed for each method.
Conclusion: Each mode of ABI calculation presents its own optimal cut-
off value to predict mortality. The use of the single 0.90 threshold to compare
different modes of ABI calculation is inappropriate. The ABI mode of calcu-
lation and the threshold should be considered altogether. The ability of the
ABI to predict mortality is almost similar among different modes of calcula-
tion.
(Voir tableau page suivante)
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A randomized, double-blind placebo-controlled study of NV1FGF
gene therapy in critical limb ischemia patients (TAMARIS Study).
Rationale, design and baseline patient characteristics.
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Background: Patients with critical limb ischemia (CLI) unsuitable for
revascularization have a high rate of amputation and mortality (30% and 25%
at 1 year respectively Local gene therapy using plasmid DNA encoding acidic
fibroblast growth factor (NV1FGF, riferminogene pacaplasmid) showed prom-
ising results in a phase II trial on amputation free survival. This report pro-
vides the rationale, design and baseline characteristics of CLI patients enrolled
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to the pivotal phase III trial (TAMARIS). It also describes baseline character-
istics by diabetes status and region of origin.
Methods: An international, double-blind, placebo-controlled, randomized
study included 525 CLI patients worldwide who were unsuitable for revascu-
larization and had non-healing skin lesions, to evaluate whether repeated intra-
muscular administration of NV1FGF results in reduction of major amputations
or deaths at 1 year.
Results: Mean age of the population was 70±10 years including 70%
males and 53% diabetic patients.  Fifty four percent of the population had pre-
vious lower extremity revascularization and 22% had previous minor amputa-
tion of the index leg.   Ninety six percent of patients had an ankle pressure <
70 mmHg and/or a toe pressure < 50 mmHg or a TcPO2 < 30mmHg.  In 94%
the index leg had distal occlusive disease affecting arteries below the knee.
Statins were prescribed in 54% of patients, and antiplatelet drugs in 80%.
Variation in region of origin resulted in only minor demographic imbalance.
Patients with diabetes had more risk factors including history of coronary
artery disease, but were similar to non-diabetic patients regarding limb haemo-
dynamics and vascular lesions.
Conclusion: The clinical and vascular anatomy presentation of patients
with CLI with ischemic skin lesions who were unsuitable for revascularization
was homogeneous with little imbalance according to region of origin or dia-
betic status. The findings from this large CLI cohort are important for the
understanding of the epidemiology of the disease.
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Objective: The aim of the study was to estimate how the ultrasound
parameters of the renal arteries correlate with clinical events at hypertensive
patients (pts) with or without diabetes mellitus (DM). 
Material and method: 50 hypertensive pts (mean age = 61.3 ± 7.8 years,
52 % males) - group1, and 50 hypertensive pts with DM , matched for age and
sex (mean age = 62.7 ± 7.3 years, 54 % males) - group2.
Vascular ultrasound parameters performed in renal arteries were: peak sys-
tolic velocity (PSV), resistance index (RI), end-diastolic velocity (EDV), sys-
tolic acceleration time (SAT), renal versus aortic systolic velocity ratio (RAR).
All pts were evaluated during one year in order to detect the following com-
plications: unstable angina (UA), non-ST-segment-elevation myocardial inf-
arction (NSTEMI), chronic kidney disease (CKD), ischemic stroke (IS). 
Results: In group1, UA was significantly associated with higher RI (0.76
± 0.08 vs 0.57 ± 0.11 , p=0.03). In the same group, CKD was found in a sig-
nificantly proportion at pts with longer SAT (73 ± 1.2 ms vs 48 ± 1.4 ms,
p=0.01). In group2, UA was significantly associated with greater RI (0.75 ±
0.09 vs 0.59 ± 0.07 , p=0.02). NSTEMI was significantly more frequent at pts
with greater RI (0.78 ± 0.08 vs 0.56 ± 0.12 , p=0.01) and with higher RAR
(3.6 ± 0.2 vs 2.1 ± 0.3 , p=0.04). In the same group, CKD was found in a sig-
nificantly higher proportion at pts with longer SAT (72 ± 1.1 ms vs 45 ± 1.3
ms, p=0.008) and with higher RAR (3.7 ± 0.1 vs 2.3 ± 0.2 , p=0.04).
Conclusions: Higher RI and greater RAR seem to predict a worse mid
term outcome (one year) concerning cardiovascular events at hypertensive pts,
especially with DM. Moreover, greater RAR appears to have more powerful
mid term prognostic value for incidence of acute coronary syndromes without
ST-segment-elevation at hypertensive pts with DM. Longer SAT may have a
relative good correlation with the development of CKD in both groups of pts.
Table : Comparison of 6 modes of ABI calculation to predict the 5-years mortality (abstract 237).  
ABI mode of calculation High/High Mean/High Low/High High/Mean Mean/Mean Low/Mean
AUC 0.632* 0.620 0.615 0.610 0.618 0.598
Sensitivity with 0.90 55.7% 56.7% 60.4% 53.6% 60.8% 58.8%
Specificity with 0.90 65.1% 62.3% 60.2% 63.6% 58.5% 58.6%
Optimal cutpoint 0.94 0.97 0.92 1.00 0.97 0.92
Sensitivity for optimal cutpoint 63.9% 72.2% 64.6% 72.2% 74.2% 62.9%
Specificity for optimal cutpoint 60.3% 50.6% 58.7% 48.3% 50.3% 57.5%
* p<0.05 vs. High/Mean and Low/Mean
